The transcription factor Runx1 is a key regulator of definitive hematopoiesis in the embryo and the adult. Lineage-specific expression of Runx1 involves transcription and post-transcription control through usage of alternative promoters and diverse 3UTR isoforms, respectively. We identified and mapped microRNA (miR) binding sites on Runx1 3UTR and show that miR-27a, miR-9, miR-18a, miR-30c, and miR-199a* bind and post-transcriptionally attenuate expression of Runx1. miR-27a impacts on both the shortest (0.15 kb) and longest (3.8 kb) 3UTRs and, along with additional miRs, might contribute to translation attenuation of Runx1 mRNA in the myeloid cell line 416B. Whereas levels of Runx1 mRNA in 416B and the B cell line 70Z were similar, the protein levels were not. Large amounts of Runx1 protein were found in 70Z cells, whereas only minute amounts of Runx1 protein were made in 416B cells and overexpression of Runx1 in 416B induced terminal differentiation associated with megakaryocytic markers. Induction of megakaryocytic differentiation in K562 cells by 12-o-tetradecanoylphorbol-13-acetate markedly increased miR-27a expression, concomitantly with binding of Runx1 to miR-27a regulatory region. The data indicate that miR-27a plays a regulatory role in megakaryocytic differentiation by attenuating Runx1 expression, and that, during megakaryopoiesis, Runx1 and miR-27a are engaged in a feedback loop involving positive regulation of miR-27a expression by Runx1. megakaryocyte differentiation ͉ micro RNA ͉ Runx transcription factor
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megakaryocyte differentiation ͉ micro RNA ͉ Runx transcription factor T he mammalian RUNX1 belongs to the runt domain family of transcription factors. The three family members, RUNX1, RUNX2, and RUNX3, are lineage-specific gene expression regulators in major developmental pathways (1) (2) (3) . Although all three RUNX proteins recognize the same DNA motif, the functional overlaps are minor and each has a distinct subset of biological functions. This lack of functional redundancy results from a tightly regulated spatio-temporal expression of the RUNX genes by transcriptional and post-transcriptional control mechanisms (3) (4) (5) (6) (7) .
We have previously shown that transcription of RUNX1/ Runx1 is regulated by two distantly located promoters designated P1 and P2 for the distal and proximal, respectively (4) . P1 or P2 primary transcripts are processed into a diverse repertoire of alternatively spliced mRNAs that are differentially expressed in various cell types and at different developmental stages (3). These alternatively spliced transcripts differ in their coding regions and in their 5Ј and 3ЈUTRs (8) (9) (10) . The large repertoire of Runx1 3ЈUTRs, ranging in size between 150 and 4,000 bp is generated by alternative cleavage and polyadenylation (11) . These various 3ЈUTR isoforms could play role in translation efficiency and stability of Runx1 mRNA through interactions with regulatory proteins and microRNAs (miRs) (12) . miRs are a class of regulatory, single-stranded RNAs of Ϸ22 nucleotides that attenuate gene expression post-transcriptionally through base pairing with the 3ЈUTR (13) (14) (15) (16) , thereby controlling cell proliferation and differentiation (17) (18) (19) . For most miR-target interactions, miRs seem to affect gene expression as rheostats that make fine-scale adjustments to protein output (20) .
In the mouse embryo, expression of Runx1 is first detected in the emerging hematopoietic system, including hematopoietic stem cells (21) (22) (23) , a finding that correlates well with earlier reports that homozygous disruption of Runx1 results in a complete absence of fetal liver hematopoiesis (24, 25) . Postnatally, Runx1 is highly expressed in several hematopoietic lineages including myeloid and B-and T-lymphoid cells (2, 3, 6, 26, 27) . Mx1-Cre-mediated excision of Runx1 in adult mice caused inhibition of megakaryocytic maturation, an increase in hematopoietic progenitor cells, defects in T-and B-lymphocyte development (28) (29) (30) , as well as progressive splenomegaly with an expansion of myeloid compartment resulting from increased self-renewal of myeloid progenitors (28) . Of note, as RUNX1 resides on chromosome 21, an increased gene dosage occurs in Down syndrome, the phenotypic manifestation of trisomy 21, and patients with Down syndrome have an increased risk of developing acute megakaryoblastic leukemia (31, 32) .
As a key regulator of hematopoiesis, Runx1 expression is subjected to lineage-specific regulation by miRs (33) . Fontana et al. (34) have reported that, during monocytopoiesis, Runx1 expression is attenuated by the 17-5p-20a-106a miR cluster. Here we identified potential miR binding sites within the longest (3.8 kb) 3ЈUTR of Runx1 and show that miR-27a, miR-9, miR-18a, miR-30c, and miR-199a* bind and post-transcriptionally attenuate Runx1 expression. The impact of miR-27a on the shortest (0.15 Kb) 3ЈUTR is more pronounced than on the longest (3.8 kb) 3ЈUTR. miR-27a might contribute to translation attenuation of Runx1 mRNA in the 416B myeloid cell line, as reflected in the high ratio of Runx1 mRNA/protein level in these cells. Moreover, enforced expression of Runx1 induced 416B cells to terminally differentiate and acquire megakaryocytic features. Conversely, in the 70Z cell line, which expresses similar levels of Runx1 mRNA as 416B cells, miR-27a expression is lower than in 416B cells and Runx1 is readily translated. In the K562 cell line, induction of megakaryocytic differentiation markedly increases expression of miR-27a concomitantly with the binding of Runx1 to a putative miR-27a regulatory region. Using chromatin immunoprecipitation (ChIP)-Solexa sequencing (ChIPSeq) we pinpointed Runx1 binding to this region. The data suggest that miR-27a plays a role in megakaryocytic differentiation by attenuating Runx1 expression and that, during megakaryopoiesis, Runx1 and miR-27a are engaged in a regulatory feedback loop. Runx1, which, in early hematopoiesis, is activated by upstream regulators such as the Gata2/Scl/Lmo2 complex (7, 35) , positively regulates miR-27a expression. In turn, miR-27a modulates the level of Runx1 during megakaryopoiesis.
Results

Post-Transcriptional Regulation of Runx1 in the Myeloid Progenitor
Cell Line 416B. To assess post-transcriptional regulation of Runx1 expression we compared mRNA and protein levels in two different hematopoietic cell lines, the murine myeloid progenitor cell line 416B (36) and the pre-B lymphoblast cell line 70Z/3 (37) . Quantitative RT-PCR (qRT-PCR) and Western blots indicated that, although similar levels of Runx1 mRNA were present in the two cell lines (Fig. 1A) , large amounts of Runx1 protein were found in 70Z cells whereas only minute amounts of Runx1 protein were made in 416B cells (Fig. 1B) . Furthermore, when Runx1 was overexpressed in 416B cells, it induced terminal differentiation associated with occasional appearance of binucleated cells and cells that were positively stained for the megakaryocytic marker acetylcholine esterase [supporting information (SI) Fig. S1 ]. Incubation in the presence of the proteasome inhibitor MG-132 indicated that the low level of Runx1 protein in 416B cells was not a result of proteasomemediated degradation of Runx1 (data not shown). These data raised the possibility that Runx1 expression in 416B cells is regulated post-transcriptionally by miRs and led us to investigate this possibility.
Validation of miR Binding Sites Within Runx1 3UTRs. By using the miR target prediction algorithms TargetScan (38) (39) (40) and PicTar (41), we identified putative miR binding sites along the Ϸ3.8 kb 3ЈUTR of Runx1 (Fig. S2) . Several of these potential regulators of Runx1 mRNA translation could be detected in 416B cells, including miRs 17-5p, 27a, 106a and b, 30c, and 20a and b (Fig. 1C) . miR-27a has two binding sites within the 3ЈUTR, located 99 and 126 bp downstream of the stop codon and upstream of the most 5Ј polyA signal (Fig. S3 ). This miR is therefore capable of targeting all known Runx1 mRNA isoforms (Fig. S3 ). To directly assess the impact of miR-27a on Runx1 3ЈUTRs, we cloned the 155 bp shortest 3'UTR (S3ЈUTR; GenBank accession no. D13802) into Renilla (RL) luciferase vector (pRL-S3ЈUTR). Co-transfection of pRL-S3ЈUTR and miR-27a into HEK293 cells resulted in a pronounced (Ϸ50%) reduction of luciferase activity compared with miR-negative control (miR-NC)-transfected cells ( Fig. 2A) . Mutations introduced in the 3ЈUTR miR-27a binding sites, either the first (Mut1; also see Fig. S2 ) or the second (Mut2), significantly reduced the inhibitory effect of miR-27a, and mutation in both sites [Mut (1 ϩ 2)] completely abolished it (Fig. 2 A) . Furthermore, transfection of increasing amounts of anti-miR-27a inhibitor oligonucleotide (antago-miR-27a) resulted in a dose-dependent impairment of miR-27a activity (Fig. 2B ). These data indicate that miR-27a binds to Runx1 3ЈUTR and thereby attenuates its expression. This conclusion is supported by the data presented in Fig. 2C , which show that miR-27a inhibits the production of Runx1 protein made in HEK293 by a genuine Runx1 cDNA bearing the S3ЈUTR. Moreover, miR-27a inhibited the translation of endogenous Runx1 mRNA in 70Z cells without affecting . Western blot analysis of nuclear lysates of HEK293 cells cotransfected with pcRunx1, pEGFP-3xNLS, and miR-27a and either miR-NC or miR-9 as controls. miR-9 was used as a negative control along with miR-NC, because pcRunx1 contained the S3ЈUTR lacking miR-9 binding site. EGFP3xNLS was used to monitor transfection efficiency and protein loading. Control of non-transfected cells is also indicated (Non). (D) Inhibition of endogenous Runx1 mRNA translation by miR-27a. 70Z cells were transfected with miR-27a, miR-9, and miR-NC and endogenous Runx1 mRNA and protein were monitored by qRT-PCR (Lower) and Western blots (Upper). HPRT1 was used as qRT-PCR internal control and Emerin as a control for protein loading. Ratios of Runx1/Emerin were derived by densitometry analysis using ImageJ (55) . Note that miR-27a mediates stronger effect on the protein compared with miR-9. This may be related to the proximal positioning and higher ''quality'' of miR-27a binding sites within the 3ЈUTR of Runx1 (Figs. S2 and S3 ). Neither miR-9 nor miR-27a affected the level of Runx1 mRNA, but mediated translation inhibition leading to an approximate two-to threefold decrease in the steady-state level of Runx1 protein.
mRNA levels (Fig. 2D) , underscoring the importance of miR27a in regulation of Runx1 expression. Of note, miR-9 impact on endogenous Runx1 was lower than that of miR-27a (Fig. 2D) . This occurrence could have resulted from the lower ''grade'' (39) of miR-9 binding sites on Runx1 3ЈUTR compared with miR-27a binding sites, and to their more distal location on the L3ЈUTR (see Fig. S3 ). By using transfection assays, we have similarly demonstrated that miRs 9, 18a, 30c, and 199a* attenuate Runx1 3ЈUTR-mediated expression (Fig. S4) . Interestingly, the major Runx1 isoform expressed in 416B cells seems to have a relatively long (Ϸ3 kb) 3ЈUTR (Fig. S5A) that, in addition to miR-27a, also includes binding sites for additional miRs (Figs. S2 and S3) , several of which were detected in 416B cells (Fig. 1C and data  not shown) .
The Size of Runx1-3UTR Affects the Impact of miR-27a. As (42) . We addressed whether the size of Runx1 3ЈUTR affects the impact of miR-27a on Runx1 expression.
First, we cloned a Ϸ3.8 kb fragment, corresponding to the longest Runx1 3'UTR (L3ЈUTR; GenBank accession no. AK145098), into a Firefly (FF) luciferase expression vector (pFF-L3ЈUTR). Second, we used site-directed mutagenesis to mutate the first three polyA signals [at positions (nt) 137, 388, and 732 downstream of the stop codon] of L3ЈUTR (11), to facilitate the production of longer 3ЈUTR (pFF-L*3ЈUTR). Northern blot of polyA ϩ -RNA from pFF-L*3ЈUTR-transfected HEK293 confirmed the significant size increase in the 3ЈUTR made by pFF-L*3ЈUTR (Fig. S5B) .
By using a dual luciferase assay, we compared the inhibitory effect of miR-27a on pRL-S3ЈUTR and pFF-L*3ЈUTR expression. As indicated earlier, miR-27a has two binding sites, both on the shortest (i.e., 155 bp) 3ЈUTR, and it can thus target all known Runx1 mRNA isoforms. miR-27a was approximately twofold more effective on pRL-S3ЈUTR than on pFF-L*3ЈUTR (Fig. 3) , indicating that location and ''context'' of the miR-27a site within Runx1 3ЈUTR play a role in its efficacy. miR-27a efficacy could be influenced by differences in accessibility of the binding site imposed by the secondary structure of the 3ЈUTR (43), a hypothesis supported by ''RNAfold'' analysis (43) (data not shown). We conclude that, as a result of the location/context effect, miR-27a binding sites are less accessible on L3ЈUTR compared with the S3ЈUTR, rendering the mRNAs bearing L3ЈUTR less sensitive to inhibition by miR-27a.
Systematic bias of alternative polyadenylation, regulated by both cis-elements and transacting factors, occurs in several human tissues (44) , and a shift toward mRNAs with shortened 3ЈUTR was observed after activation of primary murine CD4 ϩ T lymphocytes (45) . Similarly, the profiles of Runx1 3ЈUTR during megakaryopoiesis may shift by alternative usage of polyadenylation sites and thereby affect the ability of miR-27a to attenuate Runx1 expression.
Runx1
Regulates miR-27a During Megakaryocytic Differentiation of K562 Cells. We next addressed the possibility that Runx1 and miR-27a are engaged in a mutual regulatory loop using the K562 leukemia cell line (46) , which expresses both Runx1 and miR27a. K562 cells are a common progenitor of megakaryocytic and erythroid lineage that can be induced to differentiate into erythrocytes or megakaryocytes by treatment with hemin or phorbol 12-o-tetradecanoylphorbol-13-acetate (TPA), respectively (47) . Consistent with the observation that forced expression of Runx1 in 416B led to their terminal differentiation into the megakaryocytic lineage (Fig. S1 ), TPA-mediated differentiation of K562 cells was associated with increased expression of RUNX1 (5, 48) . Significantly, a marked induction of miR-27a expression was observed following TPA treatment (Fig. 4A) , raising the possibility that RUNX1 directly regulates miR-27a transcription. Compatible with this hypothesis, ChIP using the human acute megakaryocytic leukemia cell line CMK with anti-RUNX1 Ab followed by Solexa sequencing (i.e., ChIP-Seq) revealed a highly conserved putative regulatory region containing two consensus RUNX binding sites Ϸ10 kb upstream of the miR-27a locus (Fig. 4 B and C) . To confirm the biological significance of RUNX1 binding to this region, we next performed ChIP-PCR analysis of TPA-treated and untreated K562 cells. TPA treatment markedly enhanced the binding of RUNX1 to this region (Fig. 4D) . The results indicate that, upon induction of megakaryocytic differentiation, RUNX1 binds to a putative miR-27a regulatory region and up-regulates its expression. Collectively, the data presented here support the notion that, during megakaryopoiesis, RUNX1 activity is modulated by miR-27a and that Runx1 and miR-27a are engaged in a mutual regulatory loop.
Discussion
Runx1 is an important cell lineage-specific regulator of hematopoiesis. Its expression is tightly controlled by a combination of transcriptional and post-transcriptional mechanisms, including long range enhancer-mediated transcription and alternative usage of the P1/P2 promoters, which generate multiple mRNA isoforms differing in their 5Ј-and 3Ј-UTRs (3, 6, 7) .
Runx1 expression in the early myeloid progenitor cell line 416B is largely regulated post-transcriptionally (Fig. 1) . Given the diverse repertoire of 3ЈUTRs and distinct spatial/temporal expression of Runx1 (3), the involvement of miR-mediated post-transcriptional regulation was investigated. Analysis revealed that five known miRs interact with Runx1 short and long 3ЈUTRs and affect 3ЈUTR-dependent translation. Of these miRs, miR-27a has two closely clustered binding sites located on the short 3ЈUTR (Figs. S2 and S3) , rendering all Runx1 mRNA isoforms targets to miR-27a-mediated attenuation. Furthermore, the two miR-27a binding sites have features characteristic of high-efficacy miR-binding sites (39) (see Fig. S3 ). Of note, miR binding sites for the 17-5p-20a-106a cluster regulating RUNX1 expression during monocytopoiesis (34) are confined to Runx1 L3ЈUTR (Fig. S2) , rendering the S3ЈUTR isoforms refractory to translation inhibition by the 17-5p-20a-106a cluster. Significantly, Runx1 L3ЈUTR is less sensitive to inhibition by miR-27a than the S3ЈUTR, conceivably because of differences in accessibility imposed by the secondary structure of the L3ЈUTR. Thus, differences in the profile of Runx1 mRNA isoforms in various cell lineages and during cell differentiation may affect the ability of miR-27a to attenuate Runx1 expression. We have previously reported that TPA induction of megakaryocytic differentiation in K562 cells was associated with P1/P2 promoter shift and preferential translation of the P2 internal ribosome entry site containing RUNX1 mRNA isoforms (5). Whether these internal ribosome entry sites containing mRNAs are relatively immune to miR-mediated translation attenuation (48), or whether TPA affects the 3ЈUTRs profile thereby influencing miR-27a-mediated attenuation, are interesting issues to address in the future.
The myeloid progenitor cell line 416B could form both granulocyte-and megakaryocyte-containing spleen colonies upon transplantation into irradiated mice, indicating that these cells maintain a bi-potential granulocyte/megakaryocyte differentiation capability (36) . However, 416B cells could not be induced to differentiate in vitro by a variety of known differentiation-inducing agents (36) , but forced expression of GATA1, GATA2 (49, 50), or Runx1 (Fig. S1 ) induced 416B cells to express megakaryocytic markers. This occurrence is in line with the notion that RUNX1 plays a role in megakaryocytic lineage commitment through functional and physical interactions with GATA1 (48) . Of potential relation, GATA2 is a potential target of miR-27a (38 -41) . The common progenitor megakaryocytic/erythroid cell line K562, to the contrary, can be induced to differentiate in vitro into erythrocytes or megakaryocytes by treatment with hemin or TPA, respectively (47) . We therefore used K562 cells to demonstrate that, upon induction of megakaryocytic differentiation, expression of miR-27a markedly increased, concomitantly with the binding of Runx1 to conserved RUNX binding sites upstream of miR-27a locus, indicating that, during megakaryocytic differentiation, RUNX1 acts to positively regulate transcription of miR-27a. Furthermore, by using ChIP-Seq, we showed that RUNX1 binds to a putative miR-27a regulatory region. Of note, down-regulation of miR-27a expression occurs upon induction of K562 cells toward erythroid differentiation (51) , raising the possibility that Runx1-mediated regulation of miR27a plays role in the erythroid/megakaryocytic lineage determination.
Taken together, the data indicate a role for miR-27a in attenuating Runx1 expression during megakaryocytic differentiation and support the possibility that, during megakaryopoiesis, Runx1 and miR-27a are engaged in a regulatory feedback loop. Runx1, which in early hematopoiesis is up-regulated by the Gata2/Scl/Lmo2 complex (7), positively regulates miR-27a expression. miR-27a then modulates the steady-state levels of Runx1 during megakaryopoiesis.
Materials and Methods
Cell Culture. The murine myeloid progenitor cell line 416B (36) was obtained from Marella de Bruijn (Oxford, UK) and maintained in Fischer medium (Gibco), 20% heat-inactivated horse serum (Sigma), 2 mM L-glutamine, and penicillin/streptomycin (Gibco) at 37°C with 5% CO 2. The murine pre-B lymphoblast cell line 70Z was maintained in RPMI medium 1640 (Gibco), 10% FBS (Gibco), 0.05 mM 2-mercaptoethanol, 2 mM L-glutamine (Gibco), and 1% penicillin/streptomycin (Gibco) at 37°C with 5% CO 2. The HEK293 cell line was maintained in DMEM (Gibco) supplemented with 10% FBS (Gibco), 2 mM L-glutamine (Gibco), and penicillin/streptomycin (Gibco) at 37°C with 5% CO 2. CMK and K562 cells were maintained in RPMI medium 1640 (Gibco), 10% FBS (Gibco), 2 mM L-glutamine (Gibco), and 1% penicillin/streptomycin (Gibco) at 37°C with 5% CO 2.
Protein and RNA Analysis. Cells were collected and washed once in PBS solution, and proteins or RNA were extracted and analyzed by Western or Northern blotting as previously described (52) .
qRT-PCR. Total RNA was obtained using an EZ-RNA Kit (Biological Industries) and reverse transcribed with random hexamers using SuperScript III (Invitrogen). TaqMan quantitative PCR was performed using the LightCycler 480 System (Roche) according to standard procedures. HPRT1 was used as endogenous control. Commercial ready-to-use primers/probe mixes were used (Applied Biosystems). miR qRT-PCR. miR-specific RT reactions were performed by using stem-loop RT primers and a TaqMan miRNA reverse transcription kit (Applied Biosystems). Relative quantification of miR-27a was assessed by qPCR using a TaqMan miRNA assay (Applied Biosystems). MiR-16 was used as an endogenous control (Applied Biosystems). Northern blot analysis of miR was performed as described elsewhere (53) . Using qRT-PCR data we also derived the endogenous copy number of miR-27a in the hematopoietic cell lines used in this study. 70Z and K562 cell lines contained between 500 and 1,000 copies per cell whereas 416B contained between 1,500 and 3,000 copies per cell. These miR-27a concentrations were obtained through an accurate qRT-PCR determination of the known amount of exogenously transfected miR-27a into 70Z cells, and comparisons of qRT-PCR cycle threshold differences of transfected and nontransfected 70Z cells. The endogenous concentrations of miR-27a in 416B and K562 were then determined and deduced by qRT-PCR cycle threshold in these cell lines.
Transfections and Dual-Reporter Assays. For dual luciferase assay, 3ЈUTR segments corresponding to the two Runx1 isoforms (accession nos. D13802 and AK145098; designated S3ЈUTR and L3ЈUTR, respectively) were amplified by PCR from genomic DNA and inserted into the XbaI and FseI sites of pGL4 vector (Promega), immediately downstream of the luciferase stop codon. The following primer sets were used to generate specific fragments: 3ЈUTR-F, 5Ј-ATGACATCTAGAGCTGAGCGCCATCGCCATCG-3Ј; S3ЈUTR-R, 5Ј-AGTTCAGGCCGGCCAAGGGTATAAAATCTTTCTTTTATTCACAGCATTG-3Ј; and L3ЈUTR-R, 5Ј-GAATATGGCCGGCCACCCCCAATACATGTGTTTTAC-TGCTATTTC-3Ј. HEK293 cells were co-transfected in 24-well plates with 0.1 g of the reporter vector, 0.035 g of control vector (Promega), and the relevant concentration of miRNA precursor (Ambion) or anti-miR miRNA inhibitor (Ambion) using Lipofectamine 2000 according to the manufacturer protocol (Invitrogen). Firefly and Renilla luciferase activities were measured 24 h after transfection using a dual luciferase assay kit (Promega). To mutate/delete 3-5 bp of miR seed-match sequence, we used site-directed mutagenesis by whole plasmid synthesis with PfuUltra (Stratagene). Mutations were confirmed by plasmid DNA sequencing. To assess miR-27a effect on Runx1 ectopic expression, HEK293 cells were cotransfected in 9-cm plates with 0.5 g pcRunx1, 1.5 g pcEGFP-3xNLS and miR-27a, miR-9, or miR-NC (30 nM; Dharmacon). pcRunx1 vector contains CMV promoter-driven Runx1 cDNA bearing the S3ЈUTR. Cells were harvested 48 h after transfection for protein measurement by Western blot. For transfections of mature miRs into 70Z cells, cells were co-transfected in six-well plates with the appropriate miR (150 nM; Dharmacon) and Cy3-Anti-miR-NC (15 nM; Ambion). Transfection was monitored by qRT-PCR as indicated earlier and by Cy3 fluorescence.
ChIP. ChIP assays were performed essentially as described (54) . Chromatin from Ϸ10 7 cells was fragmented to an average size of 500 bp using a Microson XL ultrasonic cell disruptor (Misonix). For immunoprecipitation, 4 l of anti-RUNX1 antibody (52) was added to 1.5 mL of soluble chromatin. Rabbit pre-immune serum was used as a control. ChIP-Seq was performed according to Solexa protocols. For ChIP-PCR analysis, an aliquot of precipitated DNA was analyzed by PCR using primers specific for the human miR-23a-27a-24 -2 upstream promoter region identified by ChIP-Seq analysis (forward primer, 5Ј-CCCAGCCGGCCCACAGGTCA; reverse primer, 5Ј-GATCCCGGCTCAGTCCATAA-CACA). Primers for human CD19 promoter region (forward primer, 5Ј-AGAAGGAGTCTATGTGCCCA; reverse primer, 5Ј-CCTCCAGACTCACAACACTT) served as an internal negative control.
